Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy
NCT04138628 · ACTIVE NOT RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by JøRgen Bjerggaard Jensen. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by JøRgen Bjerggaard Jensen.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
JøRgen Bjerggaard Jensen currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
JøRgen Bjerggaard Jensen conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.